TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 2 | -1 | 2 | 3 | 14 | 40 | 10 |
| P | %wins | 100 | 50 | 50 | 50 | 100 | 50 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/28/07 12:36 | 11/27/07 | GLGC | Gene Logic Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Urdal David | MD | D | P | 23 | 0.9000 | 0 | 25 | New | 25 | D | |||||||||||||||
6/8/06 21:44 | 6/8/06 | DNDN | Dendreon Corp | DE | Health | Drug | Pharmaceutical Preparations | Urdal David | WA | DO | SVP,Chie | P | 20 | 4.04 | 4 | 5 | 1 | 481 | 0 | -6 | 15 | 11 | 5 | 98 | |||||||||
3/18/05 21:07 | 3/17/05 | DNDN | Dendreon Corp | DE | Health | Drug | Pharmaceutical Preparations | Urdal David | WA | O | Chief Sc | P | 25 | 5.58 | 19 | 4 | 1 | 461 | D | 19 | -58 | -46 | -46 | -12 | -17 | -7 | -5 | 3 | 4 | -11 | -6 | 23 | -19 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |